Article
Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production…
Stem Cells International · 2019 · Maosheng Chen, author Jing Peng, author Qi Xie, author Na Xiao, author Xian Su, author Hua Mei, author Yeping Lu, author Jia Zhou, author Yanni Dai, author Siqi Wang, author Chuang Li, author Ge Lin, author Lamei Cheng, author Kenichi Tamama, Academic Editor
Key facts
| Title | Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs) |
|---|---|
| First author | Maosheng Chen, author Jing Peng, author Qi Xie, author Na Xiao, author Xian Su, author Hua Mei, author Yeping Lu, author Jia Zhou, author Yanni Dai, author Siqi Wang, author Chuang Li, author Ge Lin, author Lamei Cheng, author Kenichi Tamama, Academic Editor |
| Journal | Stem Cells International |
| Published | Mar 23, 2019 |
| DOI | 10.1155/2019/6961052 |
| Devices mentioned | BK110039 |
| Product codes mentioned | NJT, PPM, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1